Pathology · Cardiac Pathology (IHD, Myocardial Infarction, Valvular, Endocarditis)

Hypertrophic cardiomyopathy (HCM) is caused by mutations in sarcomere proteins. The most commonly mutated gene in familial HCM is:

  • A TNNI3 encoding cardiac troponin I exclusively
  • B MYH7 encoding beta-myosin heavy chain, or MYBPC3 encoding myosin binding protein C
  • C TTN encoding titin (largest sarcomere protein)
  • D SCN5A encoding the cardiac sodium channel
Correct answer: B. MYH7 encoding beta-myosin heavy chain, or MYBPC3 encoding myosin binding protein C

Explanation

Approximately 60–70% of familial HCM cases harbor mutations in two genes: MYH7 (encoding beta-myosin heavy chain, ~35%) and MYBPC3 (encoding cardiac myosin binding protein C, ~35%). Both are thick-filament proteins. The mutations produce sarcomere hypercontractility through various gain-of-function and dominant-negative mechanisms. TNNI3 mutations account for a minority of cases. Titin (TTN) mutations predominantly cause dilated cardiomyopathy. SCN5A mutations cause Brugada syndrome and long QT syndrome.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Cardiac Pathology (IHD, Myocardial Infarction, Valvular, Endocarditis) MCQs

See all Cardiac Pathology (IHD, Myocardial Infarction, Valvular, Endocarditis) MCQs →